RISE IN SALE PRICES OF SEVERAL MEDICINES RECORDED IN OCTOBER AND NOVEMBER

NOYAN TAPAN
NOVEMBER 17, 2009
YEREVAN

YEREVAN, NOVEMBER 17, NOYAN TAPAN. A rise in the sale prices of several
medicines has been recorded as a result of the checks conducted by
the RA State Commission for the Protection of Economic Competition in
October-November of this year. According to the preliminary study of
the Commission’s experts, the behavior of the big economic entities
engaged in the import and sale on the markets of cardiovascular,
anti-virus and diabetic medicines may bear evidence of possible
violations of the legislation on competition. For that reason, at
the November 17 sitting, the Commission initiated legal proceedings
in the indicated markets.

During the proceedings, the compliance of the behavior of the
following entities with competition rules will be examined. These
economic entities are: Esculap LLC, Argo Pharm LLC, Asteria LLC,
Alpha Pharm CJSC, Natali Pharm LLC, Vaga Pharm LLC, Arpimed CJSC,
Arpharmatsia CJSC, Amikus LLC, Lagi LLC, Deghabaza Yerevan LLC,
Rus Pharm LLC, Richter Lambron LLC, Tonus Les LLC, Pharm Gohar LLC,
Asteria LLC, Pharm Trust LLC, and Orient Pharm LLC (these economic
entities are the biggest ones in the market). At the Commission’s
sitting, the economic entities were asked to provide information about
the components of the structure of the purchase prices of goods and
their sale prices, also the reasons for a change in prices. They were
also asked to present copies of the agreements and invoices.

The list of the medicines of social importance, whose prices have been
raised in an unfounded way (in the preliminary opinion of experts)
will be available on website.